Global Health hosts investor meetings on September 17 and 18

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Global Health hosts group investor meetings on September 17 and 18, 2026
  • First session at Jefferies India Forum 2026 in Gurugram on September 17
  • Second session at Kotak Healthcare Forum 2026 in Mumbai on September 18
  • Meetings are in-person; no unpublished price-sensitive info to be shared
powered bylight_fuzz_icon
50672046

*this image is generated using AI for illustrative purposes only.

Global Health has scheduled group meetings with analysts and investors on September 17 and 18, 2026. The engagements are part of larger industry forums organized by Jefferies and Kotak.

Meeting details

The company’s management will participate in two separate group sessions across two consecutive days. These meetings serve as a platform for direct engagement with market participants. No unpublished price-sensitive information is proposed to be shared during these interactions.

Parameter Details
Meeting dates September 17 and 18, 2026
Participants Analysts and investors
Format Group meetings

Schedule specifics

The first session is scheduled for September 17, 2026, as part of the Jefferies India Forum 2026. This meeting will be held in person in Gurugram. The second session follows on September 18, 2026, under the Kotak Healthcare Forum 2026 banner, taking place in person in Mumbai.

Global Health Limited confirmed these details pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule remains subject to change in case of unforeseen circumstances.

Historical Stock Returns for Global Health

1 Day5 Days1 Month6 Months1 Year5 Years
-0.85%+2.11%-1.96%+30.94%+5.59%0.0%

How might the insights shared at the Jefferies and Kotak forums influence Global Health's stock valuation in the immediate quarter following September 2026?

What specific strategic initiatives or pipeline updates is Global Health likely to highlight to differentiate itself from competitors during these healthcare sector forums?

Could the direct engagement with analysts signal an upcoming capital raising effort or M&A activity for Global Health in late 2026 or early 2027?

Global Health reschedules Jefferies investor meet to September 15 in Noida

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Global Health reschedules Jefferies-organized investor meet to September 15, 2026
  • Location shifted from Lucknow to Noida for the in-person group session
  • No unpublished price-sensitive information will be shared during the meeting
  • Schedule subject to change based on unforeseen circumstances
powered bylight_fuzz_icon
50512662

*this image is generated using AI for illustrative purposes only.

Global Health has revised the schedule for its upcoming group meeting with investors and analysts. The session, organized by Jefferies, is now scheduled for September 15, 2026, in Noida.

The company disclosed the updated schedule pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Management representatives will attend the meeting to engage with market participants.

Meeting Details

Date Type Location Mode
September 15, 2026 Group Noida In Person

Global Health stated that no unpublished price-sensitive information is proposed to be shared during the interaction. The company noted that the schedule remains subject to change due to unforeseen circumstances involving the analysts, investors, or the company itself.

Rahul Ranjan, Company Secretary & Compliance Officer, issued the intimation on September 10, 2026.

Historical Stock Returns for Global Health

1 Day5 Days1 Month6 Months1 Year5 Years
-0.85%+2.11%-1.96%+30.94%+5.59%0.0%

What strategic updates or operational milestones is Global Health likely to present at the September 15 investor meeting in Noida?

How might the rescheduling of this Jefferies-organized session impact short-term trading sentiment or analyst coverage for Global Health?

Are there specific regulatory or compliance topics under SEBI Regulation 30 that investors should prioritize during the upcoming interaction?

More News on Global Health

1 Year Returns:+5.59%